Tramadol for premature ejaculation: a systematic review and meta-analysis.

ABSTRACT:

Background

Tramadol is a centrally acting analgesic prescribed off-label for the treatment of premature ejaculation (PE). However, tramadol may cause addiction and difficulty in breathing and the beneficial effect of tramadol in PE is yet not supported by a high level of evidence. The purpose of this study was to systematically review the evidence from randomised controlled trials (RCT) for tramadol in the management of PE.

Methods

We searched bibliographic databases including MEDLINE to August 2014 for RCTs. The primary outcome was intra-vaginal ejaculatory latency time (IELT). Methodological quality of RCTs was assessed. Between-group differences in IELT and other outcomes were pooled across RCTs in a meta-analysis. Statistical and clinical between-trial heterogeneity was

SUBMITTER: Martyn-St James M 

PROVIDER: S-EPMC4417346 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature